LB-05PHASE III TRIAL EXPLORING THE COMBINATION OF BEVACIZUMAB AND LOMUSTINE IN PATIENTS WITH FIRST RECURRENCE OF A GLIOBLASTOMA: THE EORTC 26101 TRIAL

Wolfgang Wick; Aa. Brandes; Thierry Gorlia; Martin Bendszus; Felix Sahm; Walter Taal; M. J. B. Taphoorn; Julien Domont; Ahmed Idbaih; Mario Campone; Vassilis Golfinopoulos; M. J. van den Bent

doi:https://doi.org/10.1093/neuonc/nov306

doi.org/10.1093/neuonc/nov306

LB-05PHASE III TRIAL EXPLORING THE COMBINATION OF BEVACIZUMAB AND LOMUSTINE IN PATIENTS WITH FIRST RECURRENCE OF A GLIOBLASTOMA: THE EORTC 26101 TRIAL

,

,

..., M. J. van den Bent

35

Neuro-Oncology15.90

Volume: 17, Issue: suppl 5, Pages: v1.5 - v1

Published: Nov 1, 2015

Abstract

LB-05. PHASE III TRIAL EXPLORING THE COMBINATION OF BEVACIZUMAB AND LOMUSTINE IN PATIENTS WITH FIRST RECURRENCE OF A GLIOBLASTOMA: THE EORTC 26101 TRIAL W. Wick1, AA. Brandes2, T. Gorlia3, M. Bendszus1, F. Sahm1, W. Taal4, M. Taphoorn5, J. Domont6, A. Idbaih7, M. Campone8, P.M. Clement9, R. Stupp10, M. Fabbro11, F. Dubois12, C. Bais13, D. Musmeci3, M. Platten1, M. Weller10, V. Golfinopoulos3, and M. van den Bent4; University Medical Center &...

Paper Fields

Paper Details

Title

LB-05PHASE III TRIAL EXPLORING THE COMBINATION OF BEVACIZUMAB AND LOMUSTINE IN PATIENTS WITH FIRST RECURRENCE OF A GLIOBLASTOMA: THE EORTC 26101 TRIAL

DOI

doi.org/10.1093/neuonc/nov306

Published Date

Nov 1, 2015

Journal

Neuro-Oncology

Volume

17

Issue

suppl 5

Pages

v1.5 - v1

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Learn more

Notes

History